| 2024-11-20 | -0.05 % |
|
| 2024-11-19 | -0.57 % |
|
| 2024-11-18 | +0.87 % |
|
| 2024-11-13 | +0.35 % |
|
| 2024-11-08 | +1.47 % |
|
| 2024-11-06 | +0.17 % |
|
| 2024-11-04 | -0.39 % |
|
| 2024-11-01 | +2.88 % |
|
| 2024-10-31 | +1.3 % |
|
| 2024-10-30 | -0.2 % |
|
| 2024-10-29 | -0.56 % |
|
| 2024-10-28 | +0.66 % |
|
| 2024-10-25 | -1.44 % |
|
| 2024-10-24 | -0.03 % |
|
| 2024-10-23 | -0.09 % |
|
| 2024-10-22 | -0.76 % |
|
| 2024-10-18 | -0.4 % |
|
| 2024-10-17 | -0.5 % |
|
| 2024-10-16 | +0.06 % |
|
| 2024-10-15 | +1.13 % |
|
| 2024-10-14 | +0.75 % |
|
| 2024-10-11 | +1.42 % |
|
| 2024-10-10 | -0.93 % |
|
| 2024-10-09 | -0.16 % |
|
| 2024-10-08 | -0.5 % |
|
| 2024-10-04 | +0.12 % |
|
| 2024-10-03 | -2.02 % |
|
| 2024-10-01 | +1.48 % |
|
| 2024-09-30 | -0.31 % |
|
| 2024-09-27 | +0.93 % |
|
| 2024-09-26 | -0.65 % |
|
| 2024-09-24 | -0.15 % |
|
| 2024-09-20 | +0.8 % |
|
| 2024-09-19 | -0.87 % |
|
| 2024-09-17 | -0.76 % |
|
| 2024-09-16 | -0.19 % |
|
| 2024-09-13 | +0.79 % |
|
| 2024-09-09 | +0.27 % |
|
| 2024-09-06 | -0.04 % |
|
| 2024-09-05 | +0.39 % |
|
| 2024-09-04 | +1.9 % |
|
| 2024-09-03 | +1.77 % |
|
| 2024-08-30 | +0.67 % |
|
| 2024-08-14 | +0.62 % |
|
| 2024-08-13 | +1.3 % |
|
| 2024-08-08 | +0.37 % |
|
| 2024-08-07 | +0.4 % |
|
| 2024-08-06 | +0.39 % |
|
| 2024-08-05 | -0.99 % |
|
| 2024-08-02 | +7.42 % |
- Clorox (CLX) stock surged 7.42% after Church & Dwight (CHD) reported strong second-quarter earnings that exceeded expectations with a 4.7% organic sales growth and higher-than-expected adjusted earnings per share, driven by effective product launches and market share gains.
The rise in Clorox stock may be attributed to positive sentiment in the cleaning products sector following Church & Dwight's robust performance, potentially reflecting investor optimism about overall market trends and consumer demand for hygiene products in a competitive environment.
- The Clorox Company (NYSE: CLX) experienced a 7.42% increase in stock value following its fourth-quarter earnings report for fiscal year 2024, which highlighted strong recovery efforts post-cyber-attack, continued margin expansion, and strategic plans for growth through brand investment and innovation.
Clorox's stock rose due to investor optimism surrounding its recovery strategies, consistent improvement in profit margins, and positive future earnings outlook despite recent market challenges.
- Clorox (CLX) shares rose by 7.42% after the company exceeded earnings expectations due to higher prices and effective cost-cutting measures.
- Clorox (CLX) stock rose 7.42% following Jefferies' adjustment of its price target to $148 and the company's higher-than-expected annual profit forecasts, driven by price increases and improved profit margins in the Health & Wellness segment, despite concerns about overall revenue challenges and an increasing promotional landscape in the industry.
- Clorox (CLX) stock surged 7.4% due to better-than-expected quarterly profits, driven by a streamlined operating model focused on cost reductions, gross margin expansion, and the announcement of selling its Better Health Vitamins business.
|
| 2024-08-01 | +1.68 % |
|
| 2024-07-31 | +0.15 % |
|
| 2024-07-25 | +0.41 % |
|
| 2024-07-24 | +0.18 % |
|
| 2024-07-22 | -1.56 % |
|
| 2024-07-17 | +0.99 % |
|
| 2024-06-06 | +0.46 % |
|
| 2024-06-04 | +1.03 % |
|
| 2024-05-31 | +1.97 % |
|
| 2024-05-30 | +0.63 % |
|
| 2024-05-21 | -0.35 % |
|
